LEADER 01583oam  2200433   450 
001 9910705847803321
005 20180214134559.0
035   $a(CKB)5470000002453939
035   $a(OCoLC)995853747
035   $a(EXLCZ)995470000002453939
100   $a20170731d2017      ua             0
101 0 $aeng
135   $aurbn||||m||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aExamining the proposed Medicare part B drug demonstration $ehearing before the Committee on Finance, United States Senate, One Hundred Fourteenth Congress, second session, June 28, 2016
210  1$aWashington :$cU.S. Government Publishing Office,$d2017.
215   $a1 online resource (iii, 100 pages)
225 1 $aS. hrg. ;$v114-666
300   $aPaper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office.
320   $aIncludes bibliographical references.
517   $aExamining the proposed Medicare part B drug demonstration 
606   $aMedicare
606   $aDrugs$xPrices$xGovernment policy$zUnited States
606   $aPharmaceutical services insurance$zUnited States
608   $aLegislative hearings.$2lcgft
615  0$aMedicare.
615  0$aDrugs$xPrices$xGovernment policy
615  0$aPharmaceutical services insurance
801  0$bGPO
801  1$bGPO
801  2$bAZP
801  2$bMERUC
801  2$bGPO
906   $aBOOK
912   $a9910705847803321
996   $aExamining the proposed Medicare part B drug demonstration$93512742
997   $aUNINA